TY  - GEN
AU  - Rodriguez,R
AU  - Parker,P
AU  - Nademanee,A
AU  - Smith,D
AU  - O'Donnell,M R
AU  - Stein,A
AU  - Snyder,D S
AU  - Fung,H C
AU  - Krishnan,A Y
AU  - Popplewell,L
AU  - Cohen,S
AU  - Somlo,G
AU  - Angelopoulou,M
AU  - Al-Kadhimi,Z
AU  - Falk,P M
AU  - Spielberger,R
AU  - Kogut,N
AU  - Sahebi,F
AU  - Senitzer,D
AU  - Slovak,M
AU  - Schriber,J
AU  - Forman,S J
TI  - Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies
SN  - 0268-3369
PY  - 2005///0302
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cyclosporine
KW  - administration & dosage
KW  - Female
KW  - Graft Survival
KW  - Graft vs Host Disease
KW  - prevention & control
KW  - Hematologic Neoplasms
KW  - complications
KW  - Hematopoietic Stem Cell Transplantation
KW  - adverse effects
KW  - Humans
KW  - Male
KW  - Melphalan
KW  - Middle Aged
KW  - Mycophenolic Acid
KW  - Opportunistic Infections
KW  - Premedication
KW  - methods
KW  - Prospective Studies
KW  - Survival Analysis
KW  - Tissue Donors
KW  - Transplantation Conditioning
KW  - Treatment Outcome
KW  - Vidarabine
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1038/sj.bmt.1704493
ER  -